Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. There are three main types of NF – NF1, NF2, and schwannomatosis. While there is no cure for NF, medical treatments have been developed to help manage symptoms and slow tumor growth. In this article, we will provide an in-depth look at the various medications used in neurofibromatosis treatment.
Medications for NF1
NF1 is the most common type of neurofibromatosis. Some of the most widely used drugs for managing NF1 symptoms include:
Tyrosine Kinase Inhibitors: These drugs work by blocking proteins called tyrosine kinases that are involved in tumor growth. Two tyrosine kinase inhibitors approved for NF1 are siltuximab and sorafenib. Siltuximab is FDA approved for treating plexiform neurofibromas in children with NF1. Clinical trials have shown it can shrink these slow-growing tumors. Sorafenib also works against plexiform neurofibromas and may reduce their size.
mTOR Inhibitors: The mammalian target of rapamycin (mTOR) pathway plays a role in cell growth. Everolimus and sirolimus are mTOR inhibitors used to treat certain NF1-related tumors such as plexiform neurofibromas. In studies, these drugs halted tumor growth or caused minor shrinkage in some patients. Everolimus is approved to treat subcutaneous neurofibromas in adults with NF1.
Chemotherapy: Some chemotherapy drugs like carboplatin, vincristine, and taxol may be used for rapidly growing or malignant peripheral nerve sheath tumors associated with NF1. Chemotherapy is a treatment option when other options have not worked or are not appropriate. However, chemotherapy can cause harsh side effects.
Managing Symptoms in NF2
NF2 typically involves tumors growing on the nerves of the ears (acoustic neuromas). It can also cause tumors on the eyes, spine, and brain. Management options for NF2 include:
Stereotactic Radiosurgery: Techniques like gamma knife radiosurgery deliver high doses of radiation directly to tumors without damaging nearby healthy tissue. This can help shrink acoustic neuromas to preserve hearing and reduce symptoms like tinnitus and imbalance.
Surgery: surgically removing tumors is often necessary to halt their growth and prevent neurological damage. However, this invasive approach has risks and may not be possible for all tumors. It is usually reserved for larger tumors or in cases radiosurgery has failed.
Bevacizumab: Drugs like bevacizumab interfere with tumor blood vessel growth. Bevacizumab was found in clinical trials to stabilize tumor growth and reduce hearing loss in some NF2 patients with progressive vestibular schwannomas. Unlike surgery or radiation, it is a non-invasive treatment option.
Managing Pain Related to Neurofibromatosis
Neurofibromas themselves are often benign, but they can still cause significant pain by pressing on nerves and adjacent tissues. Pain management options for neurofibromatosis include:
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs like ibuprofen help reduce inflammation that may contribute to pain. They can be used for mild to moderate nerve pain.
Anticonvulsants: Medications designed to treat seizures, such as gabapentin and pregabalin are also effective against neuropathic nerve pain. They work by stabilizing nerve cell activity.
Tricyclic Antidepressants: Drugs like amitriptyline and nortriptyline are used at low doses to relieve several types of chronic pain, including nerve pain from NF tumors.
Opioids: Stronger pain relievers like oxycodone or hydrocodone may be needed if less potent options do not provide enough relief. Opioids must be used cautiously due to risk of dependence with long term use.
Topical Treatments: Applying lidocaine patches, creams containing capsaicin or antidepressants directly to painful areas can deliver pain relief right to targeted sites. This avoids potential systemic side effects of oral medications.
Multiple Treatment Approaches Required
As seen above, an individualized, multi-modal approach is often required to manage the symptoms of neurofibromatosis. Medications target specific molecular pathways driving tumor growth or relieve pain. For some tumors, a combination of drug therapy alongside minimally invasive procedures may provide the best outcomes. New treatments continue to be investigated through clinical trials as researchers work towards more effective NF management and hopefully a cure. Overall, available options have vastly improved the outlook for individuals facing these rare genetic conditions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
